VXRT Research and Charts

VXRT - Vaxart Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-01-06)

Last 0.94	Change ⇑ +0.10 (+0.00%)	Volume 5,478,867
	Open 0.87	High 0.96	Low 0.85

8EMA (Daily) 0.76	40EMA (Daily) 0.68	50EMA (Daily) 0.68	STO (Daily) 75.184	MACD Hist (Daily) 0.072
8EMA (Weekly) 0.756	40EMA (Weekly) 0.78	50EMA (Weekly) 0.81	STO (Weekly) 52.275	MACD Hist (Weekly) 0.053


Company Profile
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.